img

Global Monoclonal Antibodies Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Monoclonal Antibodies Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
Monoclonal Antibodies report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Monoclonal Antibodies market is projected to reach US$ 144360 million in 2034, increasing from US$ 105790 million in 2022, with the CAGR of 4.5% during the period of 2024 to 2034. Demand from Anti-Cancer and Anti-Inflammatory/Autoimmune are the major drivers for the industry.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Monoclonal Antibodies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Segment by Type
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others

Segment by Application


Anti-Cancer
Anti-Inflammatory/Autoimmune

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Monoclonal Antibodies market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Monoclonal Antibodies, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Monoclonal Antibodies industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Monoclonal Antibodies in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Monoclonal Antibodies introduction, etc. Monoclonal Antibodies Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Monoclonal Antibodies market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Monoclonal Antibodies Market Overview
1.1 Monoclonal Antibodies Product Overview
1.2 Monoclonal Antibodies Market Segment by Type
1.2.1 Erythropoietin (EPO)
1.2.2 Human Growth Hormone (HGH)
1.2.3 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.4 Monoclonal Antibody (mAb)
1.2.5 Insulin
1.2.6 Interferon (IFN)
1.2.7 Others
1.3 Global Monoclonal Antibodies Market Size by Type
1.3.1 Global Monoclonal Antibodies Market Size Overview by Type (2024-2034)
1.3.2 Global Monoclonal Antibodies Historic Market Size Review by Type (2024-2024)
1.3.3 Global Monoclonal Antibodies Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Monoclonal Antibodies Sales Breakdown by Type (2024-2024)
1.4.2 Europe Monoclonal Antibodies Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Monoclonal Antibodies Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Monoclonal Antibodies Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Monoclonal Antibodies Sales Breakdown by Type (2024-2024)
2 Global Monoclonal Antibodies Market Competition by Company
2.1 Global Top Players by Monoclonal Antibodies Sales (2024-2024)
2.2 Global Top Players by Monoclonal Antibodies Revenue (2024-2024)
2.3 Global Top Players by Monoclonal Antibodies Price (2024-2024)
2.4 Global Top Manufacturers Monoclonal Antibodies Manufacturing Base Distribution, Sales Area, Product Type
2.5 Monoclonal Antibodies Market Competitive Situation and Trends
2.5.1 Monoclonal Antibodies Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Monoclonal Antibodies Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2022)
2.7 Date of Key Manufacturers Enter into Monoclonal Antibodies Market
2.8 Key Manufacturers Monoclonal Antibodies Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Monoclonal Antibodies Status and Outlook by Region
3.1 Global Monoclonal Antibodies Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Monoclonal Antibodies Historic Market Size by Region
3.2.1 Global Monoclonal Antibodies Sales in Volume by Region (2024-2024)
3.2.2 Global Monoclonal Antibodies Sales in Value by Region (2024-2024)
3.2.3 Global Monoclonal Antibodies Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Monoclonal Antibodies Forecasted Market Size by Region
3.3.1 Global Monoclonal Antibodies Sales in Volume by Region (2024-2034)
3.3.2 Global Monoclonal Antibodies Sales in Value by Region (2024-2034)
3.3.3 Global Monoclonal Antibodies Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Monoclonal Antibodies by Application
4.1 Monoclonal Antibodies Market Segment by Application
4.1.1 Anti-Cancer
4.1.2 Anti-Inflammatory/Autoimmune
4.2 Global Monoclonal Antibodies Market Size by Application
4.2.1 Global Monoclonal Antibodies Market Size Overview by Application (2024-2034)
4.2.2 Global Monoclonal Antibodies Historic Market Size Review by Application (2024-2024)
4.2.3 Global Monoclonal Antibodies Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Monoclonal Antibodies Sales Breakdown by Application (2024-2024)
4.3.2 Europe Monoclonal Antibodies Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Monoclonal Antibodies Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Monoclonal Antibodies Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Monoclonal Antibodies Sales Breakdown by Application (2024-2024)
5 North America Monoclonal Antibodies by Country
5.1 North America Monoclonal Antibodies Historic Market Size by Country
5.1.1 North America Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Monoclonal Antibodies Sales in Volume by Country (2024-2024)
5.1.3 North America Monoclonal Antibodies Sales in Value by Country (2024-2024)
5.2 North America Monoclonal Antibodies Forecasted Market Size by Country
5.2.1 North America Monoclonal Antibodies Sales in Volume by Country (2024-2034)
5.2.2 North America Monoclonal Antibodies Sales in Value by Country (2024-2034)
6 Europe Monoclonal Antibodies by Country
6.1 Europe Monoclonal Antibodies Historic Market Size by Country
6.1.1 Europe Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Monoclonal Antibodies Sales in Volume by Country (2024-2024)
6.1.3 Europe Monoclonal Antibodies Sales in Value by Country (2024-2024)
6.2 Europe Monoclonal Antibodies Forecasted Market Size by Country
6.2.1 Europe Monoclonal Antibodies Sales in Volume by Country (2024-2034)
6.2.2 Europe Monoclonal Antibodies Sales in Value by Country (2024-2034)
7 Asia-Pacific Monoclonal Antibodies by Region
7.1 Asia-Pacific Monoclonal Antibodies Historic Market Size by Region
7.1.1 Asia-Pacific Monoclonal Antibodies Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Monoclonal Antibodies Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Monoclonal Antibodies Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Monoclonal Antibodies Forecasted Market Size by Region
7.2.1 Asia-Pacific Monoclonal Antibodies Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Monoclonal Antibodies Sales in Value by Region (2024-2034)
8 Latin America Monoclonal Antibodies by Country
8.1 Latin America Monoclonal Antibodies Historic Market Size by Country
8.1.1 Latin America Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Monoclonal Antibodies Sales in Volume by Country (2024-2024)
8.1.3 Latin America Monoclonal Antibodies Sales in Value by Country (2024-2024)
8.2 Latin America Monoclonal Antibodies Forecasted Market Size by Country
8.2.1 Latin America Monoclonal Antibodies Sales in Volume by Country (2024-2034)
8.2.2 Latin America Monoclonal Antibodies Sales in Value by Country (2024-2034)
9 Middle East and Africa Monoclonal Antibodies by Country
9.1 Middle East and Africa Monoclonal Antibodies Historic Market Size by Country
9.1.1 Middle East and Africa Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Monoclonal Antibodies Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Monoclonal Antibodies Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Monoclonal Antibodies Forecasted Market Size by Country
9.2.1 Middle East and Africa Monoclonal Antibodies Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Monoclonal Antibodies Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Biocon
10.1.1 Biocon Company Information
10.1.2 Biocon Introduction and Business Overview
10.1.3 Biocon Monoclonal Antibodies Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Biocon Monoclonal Antibodies Products Offered
10.1.5 Biocon Recent Development
10.2 Celltrion
10.2.1 Celltrion Company Information
10.2.2 Celltrion Introduction and Business Overview
10.2.3 Celltrion Monoclonal Antibodies Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Celltrion Monoclonal Antibodies Products Offered
10.2.5 Celltrion Recent Development
10.3 Dr. Reddy's Laboratories
10.3.1 Dr. Reddy's Laboratories Company Information
10.3.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Products Offered
10.3.5 Dr. Reddy's Laboratories Recent Development
10.4 Hospira
10.4.1 Hospira Company Information
10.4.2 Hospira Introduction and Business Overview
10.4.3 Hospira Monoclonal Antibodies Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Hospira Monoclonal Antibodies Products Offered
10.4.5 Hospira Recent Development
10.5 3SBio
10.5.1 3SBio Company Information
10.5.2 3SBio Introduction and Business Overview
10.5.3 3SBio Monoclonal Antibodies Sales, Revenue and Gross Margin (2024-2024)
10.5.4 3SBio Monoclonal Antibodies Products Offered
10.5.5 3SBio Recent Development
10.6 Accord Healthcare
10.6.1 Accord Healthcare Company Information
10.6.2 Accord Healthcare Introduction and Business Overview
10.6.3 Accord Healthcare Monoclonal Antibodies Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Accord Healthcare Monoclonal Antibodies Products Offered
10.6.5 Accord Healthcare Recent Development
10.7 AET Biotech
10.7.1 AET Biotech Company Information
10.7.2 AET Biotech Introduction and Business Overview
10.7.3 AET Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2024-2024)
10.7.4 AET Biotech Monoclonal Antibodies Products Offered
10.7.5 AET Biotech Recent Development
10.8 Allergan
10.8.1 Allergan Company Information
10.8.2 Allergan Introduction and Business Overview
10.8.3 Allergan Monoclonal Antibodies Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Allergan Monoclonal Antibodies Products Offered
10.8.5 Allergan Recent Development
10.9 Amega Biotech
10.9.1 Amega Biotech Company Information
10.9.2 Amega Biotech Introduction and Business Overview
10.9.3 Amega Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Amega Biotech Monoclonal Antibodies Products Offered
10.9.5 Amega Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Monoclonal Antibodies Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Monoclonal Antibodies Industrial Chain Analysis
11.4 Monoclonal Antibodies Market Dynamics
11.4.1 Monoclonal Antibodies Industry Trends
11.4.2 Monoclonal Antibodies Market Drivers
11.4.3 Monoclonal Antibodies Market Challenges
11.4.4 Monoclonal Antibodies Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Monoclonal Antibodies Distributors
12.3 Monoclonal Antibodies Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Erythropoietin (EPO)
Table 2. Major Company of Human Growth Hormone (HGH)
Table 3. Major Company of Granulocyte- Colony Stimulating Factor (G-CSF)
Table 4. Major Company of Monoclonal Antibody (mAb)
Table 5. Major Company of Insulin
Table 6. Major Company of Interferon (IFN)
Table 7. Major Company of Others
Table 8. Global Monoclonal Antibodies Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 9. Global Monoclonal Antibodies Sales by Type (2024-2024) & (Units)
Table 10. Global Monoclonal Antibodies Sales Market Share in Volume by Type (2024-2024)
Table 11. Global Monoclonal Antibodies Sales by Type (2024-2024) & (US& Million)
Table 12. Global Monoclonal Antibodies Market Share in Value by Type (2024-2024)
Table 13. Global Monoclonal Antibodies Price by Type (2024-2024) & (USD/Unit)
Table 14. Global Monoclonal Antibodies Sales by Type (2024-2034) & (Units)
Table 15. Global Monoclonal Antibodies Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Monoclonal Antibodies Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Monoclonal Antibodies Sales Market Share in Value by Type (2024-2034)
Table 18. Global Monoclonal Antibodies Price by Type (2024-2034) & (USD/Unit)
Table 19. North America Monoclonal Antibodies Sales by Type (2024-2024) & (Units)
Table 20. North America Monoclonal Antibodies Sales by Type (2024-2024) & (US$ Million)
Table 21. Europe Monoclonal Antibodies Sales (Units) by Type (2024-2024)
Table 22. Europe Monoclonal Antibodies Sales by Type (2024-2024) & (US$ Million)
Table 23. Asia-Pacific Monoclonal Antibodies Sales (Units) by Type (2024-2024)
Table 24. Asia-Pacific Monoclonal Antibodies Sales by Type (2024-2024) & (US$ Million)
Table 25. Latin America Monoclonal Antibodies Sales (Units) by Type (2024-2024)
Table 26. Latin America Monoclonal Antibodies Sales by Type (2024-2024) & (US$ Million)
Table 27. Middle East and Africa Monoclonal Antibodies Sales (Units) by Type (2024-2024)
Table 28. Middle East and Africa Monoclonal Antibodies Sales by Type (2024-2024) & (US$ Million)
Table 29. Global Monoclonal Antibodies Sales by Company (2024-2024) & (Units)
Table 30. Global Monoclonal Antibodies Sales Share by Company (2024-2024)
Table 31. Global Monoclonal Antibodies Revenue by Company (2024-2024) & (US$ Million)
Table 32. Global Monoclonal Antibodies Revenue Share by Company (2024-2024)
Table 33. Global Market Monoclonal Antibodies Price by Company (2024-2024) & (USD/Unit)
Table 34. Global Monoclonal Antibodies Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2022)
Table 37. Date of Key Manufacturers Enter into Monoclonal Antibodies Market
Table 38. Key Manufacturers Monoclonal Antibodies Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Monoclonal Antibodies Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 41. Global Monoclonal Antibodies Sales by Region (2024-2024) & (Units)
Table 42. Global Monoclonal Antibodies Sales Market Share in Volume by Region (2024-2024)
Table 43. Global Monoclonal Antibodies Sales by Region (2024-2024) & (US$ Million)
Table 44. Global Monoclonal Antibodies Sales Market Share in Value by Region (2024-2024)
Table 45. Global Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 46. Global Monoclonal Antibodies Sales by Region (2024-2034) & (Units)
Table 47. Global Monoclonal Antibodies Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Monoclonal Antibodies Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Monoclonal Antibodies Sales Market Share in Value by Region (2024-2034)
Table 50. Global Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 51. Global Monoclonal Antibodies Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 52. Global Monoclonal Antibodies Sales by Application (2024-2024) & (Units)
Table 53. Global Monoclonal Antibodies Sales Market Share in Volume by Application (2024-2024)
Table 54. Global Monoclonal Antibodies Sales by Application (2024-2024) & (US$ Million)
Table 55. Global Monoclonal Antibodies Sales Market Share in Value by Application (2024-2024)
Table 56. Global Monoclonal Antibodies Price by Application (2024-2024) & (USD/Unit)
Table 57. Global Monoclonal Antibodies Sales by Application (2024-2034) & (Units)
Table 58. Global Monoclonal Antibodies Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Monoclonal Antibodies Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Monoclonal Antibodies Sales Market Share in Value by Application (2024-2034)
Table 61. Global Monoclonal Antibodies Price by Application (2024-2034) & (USD/Unit)
Table 62. North America Monoclonal Antibodies Sales by Application (2024-2024) (Units)
Table 63. North America Monoclonal Antibodies Sales by Application (2024-2024) & (US$ Million)
Table 64. Europe Monoclonal Antibodies Sales by Application (2024-2024) (Units)
Table 65. Europe Monoclonal Antibodies Sales by Application (2024-2024) & (US$ Million)
Table 66. Asia-Pacific Monoclonal Antibodies Sales by Application (2024-2024) (Units)
Table 67. Asia-Pacific Monoclonal Antibodies Sales by Application (2024-2024) & (US$ Million)
Table 68. Latin America Monoclonal Antibodies Sales by Application (2024-2024) (Units)
Table 69. Latin America Monoclonal Antibodies Sales by Application (2024-2024) & (US$ Million)
Table 70. Middle East and Africa Monoclonal Antibodies Sales by Application (2024-2024) (Units)
Table 71. Middle East and Africa Monoclonal Antibodies Sales by Application (2024-2024) & (US$ Million)
Table 72. North America Monoclonal Antibodies Sales by Country (2024-2024) & (Units)
Table 73. North America Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2024)
Table 74. North America Monoclonal Antibodies Sales by Country (2024-2024) & (US$ Million)
Table 75. North America Monoclonal Antibodies Sales Market Share in Value by Country (2024-2024)
Table 76. North America Monoclonal Antibodies Sales by Country (2024-2034) & (Units)
Table 77. North America Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Monoclonal Antibodies Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Monoclonal Antibodies Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Monoclonal Antibodies Sales by Country (2024-2024) & (Units)
Table 81. Europe Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2024)
Table 82. Europe Monoclonal Antibodies Sales by Country (2024-2024) & (US$ Million)
Table 83. Europe Monoclonal Antibodies Sales Market Share in Value by Country (2024-2024)
Table 84. Europe Monoclonal Antibodies Sales by Country (2024-2034) & (Units)
Table 85. Europe Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Monoclonal Antibodies Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Monoclonal Antibodies Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Monoclonal Antibodies Sales by Region (2024-2024) & (Units)
Table 89. Asia-Pacific Monoclonal Antibodies Sales Market Share in Volume by Region (2024-2024)
Table 90. Asia-Pacific Monoclonal Antibodies Sales by Region (2024-2024) & (US$ Million)
Table 91. Asia-Pacific Monoclonal Antibodies Sales Market Share in Value by Region (2024-2024)
Table 92. Asia-Pacific Monoclonal Antibodies Sales by Region (2024-2034) & (Units)
Table 93. Asia-Pacific Monoclonal Antibodies Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Monoclonal Antibodies Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Monoclonal Antibodies Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Monoclonal Antibodies Sales by Country (2024-2024) & (Units)
Table 97. Latin America Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2024)
Table 98. Latin America Monoclonal Antibodies Sales by Country (2024-2024) & (US$ Million)
Table 99. Latin America Monoclonal Antibodies Sales Market Share in Value by Country (2024-2024)
Table 100. Latin America Monoclonal Antibodies Sales by Country (2024-2034) & (Units)
Table 101. Latin America Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Monoclonal Antibodies Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Monoclonal Antibodies Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Monoclonal Antibodies Sales by Country (2024-2024) & (Units)
Table 105. Middle East and Africa Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2024)
Table 106. Middle East and Africa Monoclonal Antibodies Sales by Country (2024-2024) & (US$ Million)
Table 107. Middle East and Africa Monoclonal Antibodies Sales Market Share in Value by Country (2024-2024)
Table 108. Middle East and Africa Monoclonal Antibodies Sales by Country (2024-2034) & (Units)
Table 109. Middle East and Africa Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Monoclonal Antibodies Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Monoclonal Antibodies Sales Market Share in Value by Country (2024-2034)
Table 112. Biocon Company Information
Table 113. Biocon Introduction and Business Overview
Table 114. Biocon Monoclonal Antibodies Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 115. Biocon Monoclonal Antibodies Product
Table 116. Biocon Recent Development
Table 117. Celltrion Company Information
Table 118. Celltrion Introduction and Business Overview
Table 119. Celltrion Monoclonal Antibodies Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 120. Celltrion Monoclonal Antibodies Product
Table 121. Celltrion Recent Development
Table 122. Dr. Reddy's Laboratories Company Information
Table 123. Dr. Reddy's Laboratories Introduction and Business Overview
Table 124. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 125. Dr. Reddy's Laboratories Monoclonal Antibodies Product
Table 126. Dr. Reddy's Laboratories Recent Development
Table 127. Hospira Company Information
Table 128. Hospira Introduction and Business Overview
Table 129. Hospira Monoclonal Antibodies Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 130. Hospira Monoclonal Antibodies Product
Table 131. Hospira Recent Development
Table 132. 3SBio Company Information
Table 133. 3SBio Introduction and Business Overview
Table 134. 3SBio Monoclonal Antibodies Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 135. 3SBio Monoclonal Antibodies Product
Table 136. 3SBio Recent Development
Table 137. Accord Healthcare Company Information
Table 138. Accord Healthcare Introduction and Business Overview
Table 139. Accord Healthcare Monoclonal Antibodies Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 140. Accord Healthcare Monoclonal Antibodies Product
Table 141. Accord Healthcare Recent Development
Table 142. AET Biotech Company Information
Table 143. AET Biotech Introduction and Business Overview
Table 144. AET Biotech Monoclonal Antibodies Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 145. AET Biotech Monoclonal Antibodies Product
Table 146. AET Biotech Recent Development
Table 147. Allergan Company Information
Table 148. Allergan Introduction and Business Overview
Table 149. Allergan Monoclonal Antibodies Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 150. Allergan Monoclonal Antibodies Product
Table 151. Allergan Recent Development
Table 152. Amega Biotech Company Information
Table 153. Amega Biotech Introduction and Business Overview
Table 154. Amega Biotech Monoclonal Antibodies Sales (Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 155. Amega Biotech Monoclonal Antibodies Product
Table 156. Amega Biotech Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Monoclonal Antibodies Market Trends
Table 160. Monoclonal Antibodies Market Drivers
Table 161. Monoclonal Antibodies Market Challenges
Table 162. Monoclonal Antibodies Market Restraints
Table 163. Monoclonal Antibodies Distributors List
Table 164. Monoclonal Antibodies Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibodies Product Picture
Figure 2. Global Monoclonal Antibodies Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Monoclonal Antibodies Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Monoclonal Antibodies Sales Status and Outlook (2024-2034) & (Units)
Figure 5. Product Picture of Erythropoietin (EPO)
Figure 6. Global Erythropoietin (EPO) Sales YoY Growth (2024-2034) & (Units)
Figure 7. Product Picture of Human Growth Hormone (HGH)
Figure 8. Global Human Growth Hormone (HGH) Sales YoY Growth (2024-2034) & (Units)
Figure 9. Product Picture of Granulocyte- Colony Stimulating Factor (G-CSF)
Figure 10. Global Granulocyte- Colony Stimulating Factor (G-CSF) Sales YoY Growth (2024-2034) & (Units)
Figure 11. Product Picture of Monoclonal Antibody (mAb)
Figure 12. Global Monoclonal Antibody (mAb) Sales YoY Growth (2024-2034) & (Units)
Figure 13. Product Picture of Insulin
Figure 14. Global Insulin Sales YoY Growth (2024-2034) & (Units)
Figure 15. Product Picture of Interferon (IFN)
Figure 16. Global Interferon (IFN) Sales YoY Growth (2024-2034) & (Units)
Figure 17. Product Picture of Others
Figure 18. Global Others Sales YoY Growth (2024-2034) & (Units)
Figure 19. Global Monoclonal Antibodies Sales by Type (2024-2034) & (US$ Million)
Figure 20. Global Monoclonal Antibodies Sales Market Share by Type in 2022 & 2034
Figure 21. North America Monoclonal Antibodies Sales Market Share in Volume by Type in 2022
Figure 22. North America Monoclonal Antibodies Sales Market Share in Value by Type in 2022
Figure 23. Europe Monoclonal Antibodies Sales Market Share in Volume by Type in 2022
Figure 24. Europe Monoclonal Antibodies Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Monoclonal Antibodies Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Monoclonal Antibodies Sales Market Share in Value by Type in 2022
Figure 27. Latin America Monoclonal Antibodies Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Monoclonal Antibodies Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Monoclonal Antibodies Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Monoclonal Antibodies Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Monoclonal Antibodies Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Monoclonal Antibodies Revenue in 2022
Figure 33. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 34. Product Picture of Anti-Cancer
Figure 35. Global Anti-Cancer Sales YoY Growth (2024-2034) & (Units)
Figure 36. Product Picture of Anti-Inflammatory/Autoimmune
Figure 37. Global Anti-Inflammatory/Autoimmune Sales YoY Growth (2024-2034) & (Units)
Figure 38. Global Monoclonal Antibodies Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Monoclonal Antibodies Sales Market Share by Application in 2022 & 2034
Figure 40. North America Monoclonal Antibodies Sales Market Share in Volume by Application in 2022
Figure 41. North America Monoclonal Antibodies Sales Market Share in Value by Application in 2022
Figure 42. Europe Monoclonal Antibodies Sales Market Share in Volume by Application in 2022
Figure 43. Europe Monoclonal Antibodies Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Monoclonal Antibodies Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Monoclonal Antibodies Sales Market Share in Value by Application in 2022
Figure 46. Latin America Monoclonal Antibodies Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Monoclonal Antibodies Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Monoclonal Antibodies Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Monoclonal Antibodies Manufacturing Cost Structure
Figure 51. Monoclonal Antibodies Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries